Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Cavaliere

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Biology Open|November 30, 2016
Innovative approaches to establish and characterize primary cultures: an <i>ex vivo</i> 3D system and the zebrafish modelChiara Liverani, Federico La Manna, Arwin Groenewoud, et al.
Biology Open|February 17, 2017
CORRECTION: Innovative approaches to establish and characterize primary cultures: an <i>ex vivo</i> 3D system and the zebrafish modelChiara Liverani, Federico La Manna, Arwin Groenewoud, et al.
Cancers|February 25, 2023
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and TrabectedinValentina Fausti, Alessandro De Vita, Silvia Vanni, et al.
Frontiers in Endocrinology|February 6, 2023
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumorsChiara Liverani, Chiara Spadazzi, Toni Ibrahim, et al.
Oncotargets and Therapy|November 4, 2014
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literatureAlberto Bongiovanni, Nada Riva, Sebastiano Calpona, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 12, 2021
The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient-derived primary culture case series in tridimensional and zebrafish modelsAlessandro De Vita, Federica Recine, Giacomo Miserocchi, et al.
Cancers|July 9, 2022
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data AnalysisNicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca, et al.
Experimental Hematology & Oncology|August 5, 2024
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatmentSilvia Vanni, Giacomo Miserocchi, Graziana Gallo, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 24, 2021
Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): A nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative GroupMaurizio Degiuli, Ugo Elmore, Raffaele De Luca, et al.
Trials|July 27, 2020
Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088)Igor Monsellato, Elisabetta Garibaldi, Elisa Cassinotti, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Biology Open|November 30, 2016
Innovative approaches to establish and characterize primary cultures: an <i>ex vivo</i> 3D system and the zebrafish modelChiara Liverani, Federico La Manna, Arwin Groenewoud, et al.
Biology Open|February 17, 2017
CORRECTION: Innovative approaches to establish and characterize primary cultures: an <i>ex vivo</i> 3D system and the zebrafish modelChiara Liverani, Federico La Manna, Arwin Groenewoud, et al.
Cancers|February 25, 2023
Systemic Inflammatory Indices in Second-Line Soft Tissue Sarcoma Patients: Focus on Lymphocyte/Monocyte Ratio and TrabectedinValentina Fausti, Alessandro De Vita, Silvia Vanni, et al.
Frontiers in Endocrinology|February 6, 2023
HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumorsChiara Liverani, Chiara Spadazzi, Toni Ibrahim, et al.
Oncotargets and Therapy|November 4, 2014
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literatureAlberto Bongiovanni, Nada Riva, Sebastiano Calpona, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 12, 2021
The potential role of the extracellular matrix in the activity of trabectedin in UPS and L-sarcoma: evidences from a patient-derived primary culture case series in tridimensional and zebrafish modelsAlessandro De Vita, Federica Recine, Giacomo Miserocchi, et al.
Cancers|July 9, 2022
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data AnalysisNicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca, et al.
Experimental Hematology & Oncology|August 5, 2024
Role of CDK4 as prognostic biomarker in Soft Tissue Sarcoma and synergistic effect of its inhibition in dedifferentiated liposarcoma sequential treatmentSilvia Vanni, Giacomo Miserocchi, Graziana Gallo, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 24, 2021
Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): A nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative GroupMaurizio Degiuli, Ugo Elmore, Raffaele De Luca, et al.
Trials|July 27, 2020
Expression levels of circulating miRNAs as biomarkers during multimodal treatment of rectal cancer - TiMiSNAR-mirna: a substudy of the TiMiSNAR Trial (NCT03962088)Igor Monsellato, Elisabetta Garibaldi, Elisa Cassinotti, et al.
Pageof 9